Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples